Skip to main content
. 2022 Nov 28;19(11):930–936. doi: 10.11909/j.issn.1671-5411.2022.11.012

Table 2. Performance measures of youngers and elderly according intervention group.

Quality markers according European Society of Cardiology (ESC 2017) Quality of Care Working Group’s consensus on quality. Before intervention After intervention
Younger Elderly P Youngers Elderly P
ACE-I: angiotensin converting enzyme inhibitors; DAPT: dual antiplatelet therapy; LVEF: left ventricular ejection fraction; STEMI: ST elevation myocardial infarction.
2. Reperfusion strategy
　2.1 Proportion of patients with STEMI arriving in the first 12 h who receiving reperfusion therapy 116/189 50/91 0.31 222/369 70/113 0.30
　2.2 For patients treated with fibrinolysis: < 30 min from diagnosis to the needle 11/116 2/50 0.22 39/222 11/70 0.72
4. In-hospital antithrombotic drugs
　4.1. Number of patients who received ≥ 1 in-hospital antithrombotic therapies. 201/203 101/101 0.99 393/393 123/123 1.0
　4.2. Number of patients who received dual antiplatelet therapy 181/203 93/101 0.42 374/393 114/123 0.28
5. Secondary prevention discharge treatment
　5.1 Proportion of patients with STEMI discharged on statins, unless contraindicated 161/182 66/80 0.19 369/375 103/105 0.82
　5.2 Proportion of patients with LVEF equal or less to 40% or clinical evidence of heart failure, with beta-blocker prescribed at discharge 13/17 11/15 0.82 50/54 13/17 0.07
　5.3 Proportion of patients with LVEF equal or less to 40% or clinical evidence of heart failure, with ACEI prescribed at discharge 14/15 17/17 0.27 52/54 15/17 0.21
　5.4 Proportion of patients with smoking cessation advice at discharge 92/124 23/35 0.32 209/233 42/45 0.49
　 5.5 Proportion of patients enrolled in secondary prevention programs 78/182 10/70 0.01 136/375 17/105 0.01
7. Outcome measures
　 In-hospital mortality rate 21/203 21/101 0.03 18/393 18/123 ≤ 0.01
　 30-day adjusted readmission rate 1/203 3/101 0.07 0/393 3/123 ≤ 0.01
8. Composite quality indicator
　Proportion of patients with LVEF equal or less to 40% or clinical evidence of heart failure, with DAPT and statins prescribed at discharge 14/15 15/17 0.62 48/54 17/17 0.15
　Proportion of patients with LVEF equal or less to 40% or clinical evidence of heart failure, with beta-blocker, ACEI, DAPT, and statins prescribed at discharge 10/15 13/17 0.53 44/54 12/17 0.33